IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, announced the appointment of Dr. William G. Kaelin Jr. to its board of ...

Phase 1 dose escalation trial in SMARCA4 (BRG1)-mutated cancer remains on track with non-small cell lung cancer ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The Blackhawks were widely expected to be one of the two worst teams in the league. Eight games in, they look much better ...

The publication reports the highly selective, DCAF16 E3 enabled degradation of BRD9 in vivo using Amphista’s proprietary, next generation ...

Region X has identified 289 barangays across Bukidnon as susceptible to rain-induced landslides and flooding ahead of the ...

Putin and Trump won’t be chatting in Hungary after negotiations on a ceasefire folded like wet paper in a stiff breeze. Trump ...

It was a weaker, er, week for healthcare stocks on the ASX, but takeover bids, trials and expansion deals kept the sector’s ...

Merck & Eisai announce Welireg plus Lenvima meets primary endpoint of PFS in certain previously treated patients with advanced RCC: Rahway, New Jersey Wednesday, October 29, 2025, ...

Data presented at the TPD and Induced Proximity Summit demonstrate that novel Selective ARID1B degrader selectively binds and degrades ARID1B; potentially relevant in up to 5% of all solid tumors ...

The ASX eased slightly as investors rotated into energy and critical minerals on soaring oil and lithium prices, while coal ...